三种新型双核 (II) 复合物与5,7-二-8-烯酸盐,具有强烈的抗癌活性
Si-Mei Qin1, Yue Xu1, Xiao-Mei Huang1
1Guangxi Key Laboratory of Agricultural Resources Chemistry and Biotechnology, College of Chemistry and Food Science, Yulin Normal University, 1303 Jiaoyudong Road, Yulin 537000, PR China. qpqin2018@126.com.
Dalton transactions (Cambridge, England : 2003)
|August 29, 2025
概括
新的 (II) 复合物在克服西斯普拉丁耐药性方面表现有前途. 这些新型化合物对抗性卵巢癌细胞具有选择性细胞毒性,诱导细胞亡和细胞亡.
科学领域:
- 无机化学
- 医学化学
- 癌症研究
背景情况:
- 在卵巢癌治疗中,对西斯普拉丁的耐药性是一个主要挑战.
- 需要新的治疗策略来克服白金抗药性.
研究的目的:
- 合成和描述新的双核 (II) 复合物.
- 评估这些复合物对抗抗西斯的卵巢癌细胞的疗效.
主要方法:
- 三个双核 (II) 复合物的合成:CaL1,CaL2和CaL3.
- 在实验室检测细胞毒性对抗抗西斯的卵巢SK-OV-3/DDP (RiSK3) 和健康的HL-7702细胞.
- 细胞亡和细胞灭的测试.
主要成果:
- 在低IC50值的RiSK3细胞中,CaL1,CaL2和CaL3具有选择性细胞毒性.
- 在RiSK3细胞中,CaL1和CaL2都诱导了细胞亡和致死性细胞灭.
- 这些复合物显示出有前途的选择性,
结论:
- 基于 (II) - 8 - 基的化合物提供了一种克服西斯抗性的潜在策略.
- 这些新型复合物代表了对抗性卵巢癌的有希望的药物候选者.
- 诱导细胞亡和细胞亡是主要的作用机制.
更多相关视频
相关概念视频
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


